Blar i Department of Global Public Health and Primary Care på tidsskrift "Atherosclerosis"
Viser treff 1-3 av 3
-
2.5-fold increased risk of recurrent acute myocardial infarction with familial hypercholesterolemia
(Journal article; Peer reviewed, 2021)Background and aims A first-time acute myocardial infarction (AMI) is a severe diagnosis that leads to initiation or intensification of lipid-lowering medication to prevent recurrent events. Individuals with familial ... -
Economic evaluation of lipid lowering with PCSK9 inhibitors in patients with familial hypercholesterolemia: Methodological aspects
(Peer reviewed; Journal article, 2019)Background and aims: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have proved to reduce low density lipoprotein cholesterol levels in numerous clinical trials. In two large clinical trials, PCSK9 inhibitor ... -
Risk of stroke in genetically verified familial hypercholesterolemia: A prospective matched cohort study
(Journal article; Peer reviewed, 2022)Background and aims Individuals with familial hypercholesterolemia (FH), causing severely elevated LDL-C, are expected to have a higher risk of ischemic stroke. The risk of hemorrhagic stroke and impact of statin use are, ...